Effect of an Intensive Lifestyle Intervention on Circulating Biomarkers of Atrial Fibrillation-Related Pathways among Adults with Metabolic Syndrome: Results from a Randomized Trial

: Lifestyles influence atrial fibrillation (AF) risk. Determining the effect of lifestyle interventions on blood concentrations of biomarkers of AF-related pathways could help understand AF pathophysiology and contribute to AF prevention. : We studied 532 participants enrolled in the PREDIMED-Plus t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2024-04, Vol.13 (7), p.2132
Hauptverfasser: Li, Linzi, Alonso, Alvaro, Romaguera, Dora, Alonso-Gómez, Angel M, Razquin, Cristina, Tojal-Sierra, Lucas, Fiol, Miquel, Martínez-González, Miguel Angel, Subramanya, Vinita, Salas-Salvadó, Jordi, Fito, Montserrat, Toledo, Estefanía
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page 2132
container_title Journal of clinical medicine
container_volume 13
creator Li, Linzi
Alonso, Alvaro
Romaguera, Dora
Alonso-Gómez, Angel M
Razquin, Cristina
Tojal-Sierra, Lucas
Fiol, Miquel
Martínez-González, Miguel Angel
Subramanya, Vinita
Salas-Salvadó, Jordi
Fito, Montserrat
Toledo, Estefanía
description : Lifestyles influence atrial fibrillation (AF) risk. Determining the effect of lifestyle interventions on blood concentrations of biomarkers of AF-related pathways could help understand AF pathophysiology and contribute to AF prevention. : We studied 532 participants enrolled in the PREDIMED-Plus trial, a Spanish randomized trial conducted in adults (55-75 years) with metabolic syndrome and body mass index between 27-40 kg/m . Eligible participants were randomized 1:1 to an intensive lifestyle intervention, emphasizing physical activity, weight loss, and adherence to an energy-reduced Mediterranean diet or to a control group. Serum biomarkers [carboxy-terminal propeptide of procollagen type I (PICP), high-sensitivity troponin T (hsTnT), high-sensitivity C reactive protein (hsCRP), 3-nitrotyrosine (3-NT), and N-terminal propeptide of B-type natriuretic peptide (NT-proBNP)] were measured at baseline, 3 and 5 years after randomization. Mixed models were used to evaluate the effect of intervention on changes in biomarkers through year 5. Mediation analysis was performed to examine the proportion mediated by each component of the intervention. : At baseline, participants' mean age was 65, 40% were female, and 50% were assigned to the intervention. After five years, mean changes in log-transformed biomarkers were -0.01 (PICP), 0.20 (hsTnT), -0.17 (hsCRP), 0.12 (3-NT), and 0.27 (NT-proBNP). Compared to the control group, participants in the intervention group experienced greater decreases in hsCRP (-14%, 95% confidence interval (CI) -26%, 0%) or smaller increases in 3-NT (-16%, 95% CI -25%, -5%) and NT-proBNP (-12%, 95% CI -23%, 1%). The intervention had minimal impact on hsTnT (-3%, 95% CI -7%, 2%) or PICP concentrations (-2%, 95% CI -9%, 6%). The effect of the intervention on hsCRP was primarily mediated by weight loss (89% at year 5). : Over five years, a dietary and lifestyle intervention for weight-loss favorably affected concentrations of hsCRP, 3-NT, and NT-proBNP, pointing to specific mechanisms in pathways linking lifestyles and AF.
doi_str_mv 10.3390/jcm13072132
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3038440248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A790019561</galeid><sourcerecordid>A790019561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-a3051f851f0c549f5993260528a4401377ef58f7fcdac9a38cb3b37a568a1f123</originalsourceid><addsrcrecordid>eNptkt9vFCEQxzdGY5vaJ98NiS8mZissuwf4dl5abXJGc9bnzSw7tJy70ALb5vy__P9k29pUIz_CMPnMlwGmKF4yesS5ou-2emSciorx6kmxX1EhSsolf_rI3isOY9zS3KSsKyaeF3tcLhiVSuwXv46NQZ2INwQcOXUJXbTXSNbWYEy7AW994Rpdst6RPFY26GmAZN05-WD9COEHhjgLLFOwMJAT2wU7zIR35QazgT35CuniBnaRwOhz4LKfhhTJjU0X5DMm6PxgNfm2c33wI74nG4y3gMlbAmQDrvej_ZmFzuYzXhTPDAwRD-_Xg-L7yfHZ6lO5_vLxdLVcl5pTlUrgtGFG5kl1UyvTKMWrBW0qCXVNGRcCTSONMLoHrYBL3fGOC2gWEphhFT8o3tzpXgZ_NeUHaUcbNebLOfRTbHl-36xU1TKjr_9Bt34KLmc3U6LmiuVPeqDOYcDWOuNTAD2LtkuhKGWqWczU0X-o3HscrfYOjc3-vwLe3gXo4GMMaNrLYPPP7FpG27lO2kd1kulX96lO3Yj9A_unKvhvF224ow</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3037439121</pqid></control><display><type>article</type><title>Effect of an Intensive Lifestyle Intervention on Circulating Biomarkers of Atrial Fibrillation-Related Pathways among Adults with Metabolic Syndrome: Results from a Randomized Trial</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Li, Linzi ; Alonso, Alvaro ; Romaguera, Dora ; Alonso-Gómez, Angel M ; Razquin, Cristina ; Tojal-Sierra, Lucas ; Fiol, Miquel ; Martínez-González, Miguel Angel ; Subramanya, Vinita ; Salas-Salvadó, Jordi ; Fito, Montserrat ; Toledo, Estefanía</creator><creatorcontrib>Li, Linzi ; Alonso, Alvaro ; Romaguera, Dora ; Alonso-Gómez, Angel M ; Razquin, Cristina ; Tojal-Sierra, Lucas ; Fiol, Miquel ; Martínez-González, Miguel Angel ; Subramanya, Vinita ; Salas-Salvadó, Jordi ; Fito, Montserrat ; Toledo, Estefanía</creatorcontrib><description>: Lifestyles influence atrial fibrillation (AF) risk. Determining the effect of lifestyle interventions on blood concentrations of biomarkers of AF-related pathways could help understand AF pathophysiology and contribute to AF prevention. : We studied 532 participants enrolled in the PREDIMED-Plus trial, a Spanish randomized trial conducted in adults (55-75 years) with metabolic syndrome and body mass index between 27-40 kg/m . Eligible participants were randomized 1:1 to an intensive lifestyle intervention, emphasizing physical activity, weight loss, and adherence to an energy-reduced Mediterranean diet or to a control group. Serum biomarkers [carboxy-terminal propeptide of procollagen type I (PICP), high-sensitivity troponin T (hsTnT), high-sensitivity C reactive protein (hsCRP), 3-nitrotyrosine (3-NT), and N-terminal propeptide of B-type natriuretic peptide (NT-proBNP)] were measured at baseline, 3 and 5 years after randomization. Mixed models were used to evaluate the effect of intervention on changes in biomarkers through year 5. Mediation analysis was performed to examine the proportion mediated by each component of the intervention. : At baseline, participants' mean age was 65, 40% were female, and 50% were assigned to the intervention. After five years, mean changes in log-transformed biomarkers were -0.01 (PICP), 0.20 (hsTnT), -0.17 (hsCRP), 0.12 (3-NT), and 0.27 (NT-proBNP). Compared to the control group, participants in the intervention group experienced greater decreases in hsCRP (-14%, 95% confidence interval (CI) -26%, 0%) or smaller increases in 3-NT (-16%, 95% CI -25%, -5%) and NT-proBNP (-12%, 95% CI -23%, 1%). The intervention had minimal impact on hsTnT (-3%, 95% CI -7%, 2%) or PICP concentrations (-2%, 95% CI -9%, 6%). The effect of the intervention on hsCRP was primarily mediated by weight loss (89% at year 5). : Over five years, a dietary and lifestyle intervention for weight-loss favorably affected concentrations of hsCRP, 3-NT, and NT-proBNP, pointing to specific mechanisms in pathways linking lifestyles and AF.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm13072132</identifier><identifier>PMID: 38610897</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Analysis ; Atrial fibrillation ; Biological markers ; Biomarkers ; Blood pressure ; Body mass index ; Cardiac arrhythmia ; Cholesterol ; Complications and side effects ; Creatinine ; Demographic aspects ; Diet ; Exercise ; Health aspects ; Inflammation ; Influence ; Life style ; Lifestyles ; Metabolic diseases ; Metabolic syndrome ; Overweight ; Oxidative stress ; Pathophysiology ; Population ; Public health ; Questionnaires ; Risk factors ; Sample size ; Weight control</subject><ispartof>Journal of clinical medicine, 2024-04, Vol.13 (7), p.2132</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-a3051f851f0c549f5993260528a4401377ef58f7fcdac9a38cb3b37a568a1f123</cites><orcidid>0000-0002-2225-8323 ; 0000-0003-2700-7459 ; 0000-0002-6263-4434 ; 0000-0002-5762-8558 ; 0000-0003-2945-7509 ; 0000-0003-3835-5598 ; 0000-0003-3480-2645 ; 0000-0002-3917-9808</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38610897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Linzi</creatorcontrib><creatorcontrib>Alonso, Alvaro</creatorcontrib><creatorcontrib>Romaguera, Dora</creatorcontrib><creatorcontrib>Alonso-Gómez, Angel M</creatorcontrib><creatorcontrib>Razquin, Cristina</creatorcontrib><creatorcontrib>Tojal-Sierra, Lucas</creatorcontrib><creatorcontrib>Fiol, Miquel</creatorcontrib><creatorcontrib>Martínez-González, Miguel Angel</creatorcontrib><creatorcontrib>Subramanya, Vinita</creatorcontrib><creatorcontrib>Salas-Salvadó, Jordi</creatorcontrib><creatorcontrib>Fito, Montserrat</creatorcontrib><creatorcontrib>Toledo, Estefanía</creatorcontrib><title>Effect of an Intensive Lifestyle Intervention on Circulating Biomarkers of Atrial Fibrillation-Related Pathways among Adults with Metabolic Syndrome: Results from a Randomized Trial</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>: Lifestyles influence atrial fibrillation (AF) risk. Determining the effect of lifestyle interventions on blood concentrations of biomarkers of AF-related pathways could help understand AF pathophysiology and contribute to AF prevention. : We studied 532 participants enrolled in the PREDIMED-Plus trial, a Spanish randomized trial conducted in adults (55-75 years) with metabolic syndrome and body mass index between 27-40 kg/m . Eligible participants were randomized 1:1 to an intensive lifestyle intervention, emphasizing physical activity, weight loss, and adherence to an energy-reduced Mediterranean diet or to a control group. Serum biomarkers [carboxy-terminal propeptide of procollagen type I (PICP), high-sensitivity troponin T (hsTnT), high-sensitivity C reactive protein (hsCRP), 3-nitrotyrosine (3-NT), and N-terminal propeptide of B-type natriuretic peptide (NT-proBNP)] were measured at baseline, 3 and 5 years after randomization. Mixed models were used to evaluate the effect of intervention on changes in biomarkers through year 5. Mediation analysis was performed to examine the proportion mediated by each component of the intervention. : At baseline, participants' mean age was 65, 40% were female, and 50% were assigned to the intervention. After five years, mean changes in log-transformed biomarkers were -0.01 (PICP), 0.20 (hsTnT), -0.17 (hsCRP), 0.12 (3-NT), and 0.27 (NT-proBNP). Compared to the control group, participants in the intervention group experienced greater decreases in hsCRP (-14%, 95% confidence interval (CI) -26%, 0%) or smaller increases in 3-NT (-16%, 95% CI -25%, -5%) and NT-proBNP (-12%, 95% CI -23%, 1%). The intervention had minimal impact on hsTnT (-3%, 95% CI -7%, 2%) or PICP concentrations (-2%, 95% CI -9%, 6%). The effect of the intervention on hsCRP was primarily mediated by weight loss (89% at year 5). : Over five years, a dietary and lifestyle intervention for weight-loss favorably affected concentrations of hsCRP, 3-NT, and NT-proBNP, pointing to specific mechanisms in pathways linking lifestyles and AF.</description><subject>Analysis</subject><subject>Atrial fibrillation</subject><subject>Biological markers</subject><subject>Biomarkers</subject><subject>Blood pressure</subject><subject>Body mass index</subject><subject>Cardiac arrhythmia</subject><subject>Cholesterol</subject><subject>Complications and side effects</subject><subject>Creatinine</subject><subject>Demographic aspects</subject><subject>Diet</subject><subject>Exercise</subject><subject>Health aspects</subject><subject>Inflammation</subject><subject>Influence</subject><subject>Life style</subject><subject>Lifestyles</subject><subject>Metabolic diseases</subject><subject>Metabolic syndrome</subject><subject>Overweight</subject><subject>Oxidative stress</subject><subject>Pathophysiology</subject><subject>Population</subject><subject>Public health</subject><subject>Questionnaires</subject><subject>Risk factors</subject><subject>Sample size</subject><subject>Weight control</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNptkt9vFCEQxzdGY5vaJ98NiS8mZissuwf4dl5abXJGc9bnzSw7tJy70ALb5vy__P9k29pUIz_CMPnMlwGmKF4yesS5ou-2emSciorx6kmxX1EhSsolf_rI3isOY9zS3KSsKyaeF3tcLhiVSuwXv46NQZ2INwQcOXUJXbTXSNbWYEy7AW994Rpdst6RPFY26GmAZN05-WD9COEHhjgLLFOwMJAT2wU7zIR35QazgT35CuniBnaRwOhz4LKfhhTJjU0X5DMm6PxgNfm2c33wI74nG4y3gMlbAmQDrvej_ZmFzuYzXhTPDAwRD-_Xg-L7yfHZ6lO5_vLxdLVcl5pTlUrgtGFG5kl1UyvTKMWrBW0qCXVNGRcCTSONMLoHrYBL3fGOC2gWEphhFT8o3tzpXgZ_NeUHaUcbNebLOfRTbHl-36xU1TKjr_9Bt34KLmc3U6LmiuVPeqDOYcDWOuNTAD2LtkuhKGWqWczU0X-o3HscrfYOjc3-vwLe3gXo4GMMaNrLYPPP7FpG27lO2kd1kulX96lO3Yj9A_unKvhvF224ow</recordid><startdate>20240407</startdate><enddate>20240407</enddate><creator>Li, Linzi</creator><creator>Alonso, Alvaro</creator><creator>Romaguera, Dora</creator><creator>Alonso-Gómez, Angel M</creator><creator>Razquin, Cristina</creator><creator>Tojal-Sierra, Lucas</creator><creator>Fiol, Miquel</creator><creator>Martínez-González, Miguel Angel</creator><creator>Subramanya, Vinita</creator><creator>Salas-Salvadó, Jordi</creator><creator>Fito, Montserrat</creator><creator>Toledo, Estefanía</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2225-8323</orcidid><orcidid>https://orcid.org/0000-0003-2700-7459</orcidid><orcidid>https://orcid.org/0000-0002-6263-4434</orcidid><orcidid>https://orcid.org/0000-0002-5762-8558</orcidid><orcidid>https://orcid.org/0000-0003-2945-7509</orcidid><orcidid>https://orcid.org/0000-0003-3835-5598</orcidid><orcidid>https://orcid.org/0000-0003-3480-2645</orcidid><orcidid>https://orcid.org/0000-0002-3917-9808</orcidid></search><sort><creationdate>20240407</creationdate><title>Effect of an Intensive Lifestyle Intervention on Circulating Biomarkers of Atrial Fibrillation-Related Pathways among Adults with Metabolic Syndrome: Results from a Randomized Trial</title><author>Li, Linzi ; Alonso, Alvaro ; Romaguera, Dora ; Alonso-Gómez, Angel M ; Razquin, Cristina ; Tojal-Sierra, Lucas ; Fiol, Miquel ; Martínez-González, Miguel Angel ; Subramanya, Vinita ; Salas-Salvadó, Jordi ; Fito, Montserrat ; Toledo, Estefanía</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-a3051f851f0c549f5993260528a4401377ef58f7fcdac9a38cb3b37a568a1f123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Analysis</topic><topic>Atrial fibrillation</topic><topic>Biological markers</topic><topic>Biomarkers</topic><topic>Blood pressure</topic><topic>Body mass index</topic><topic>Cardiac arrhythmia</topic><topic>Cholesterol</topic><topic>Complications and side effects</topic><topic>Creatinine</topic><topic>Demographic aspects</topic><topic>Diet</topic><topic>Exercise</topic><topic>Health aspects</topic><topic>Inflammation</topic><topic>Influence</topic><topic>Life style</topic><topic>Lifestyles</topic><topic>Metabolic diseases</topic><topic>Metabolic syndrome</topic><topic>Overweight</topic><topic>Oxidative stress</topic><topic>Pathophysiology</topic><topic>Population</topic><topic>Public health</topic><topic>Questionnaires</topic><topic>Risk factors</topic><topic>Sample size</topic><topic>Weight control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Linzi</creatorcontrib><creatorcontrib>Alonso, Alvaro</creatorcontrib><creatorcontrib>Romaguera, Dora</creatorcontrib><creatorcontrib>Alonso-Gómez, Angel M</creatorcontrib><creatorcontrib>Razquin, Cristina</creatorcontrib><creatorcontrib>Tojal-Sierra, Lucas</creatorcontrib><creatorcontrib>Fiol, Miquel</creatorcontrib><creatorcontrib>Martínez-González, Miguel Angel</creatorcontrib><creatorcontrib>Subramanya, Vinita</creatorcontrib><creatorcontrib>Salas-Salvadó, Jordi</creatorcontrib><creatorcontrib>Fito, Montserrat</creatorcontrib><creatorcontrib>Toledo, Estefanía</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Linzi</au><au>Alonso, Alvaro</au><au>Romaguera, Dora</au><au>Alonso-Gómez, Angel M</au><au>Razquin, Cristina</au><au>Tojal-Sierra, Lucas</au><au>Fiol, Miquel</au><au>Martínez-González, Miguel Angel</au><au>Subramanya, Vinita</au><au>Salas-Salvadó, Jordi</au><au>Fito, Montserrat</au><au>Toledo, Estefanía</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of an Intensive Lifestyle Intervention on Circulating Biomarkers of Atrial Fibrillation-Related Pathways among Adults with Metabolic Syndrome: Results from a Randomized Trial</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2024-04-07</date><risdate>2024</risdate><volume>13</volume><issue>7</issue><spage>2132</spage><pages>2132-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>: Lifestyles influence atrial fibrillation (AF) risk. Determining the effect of lifestyle interventions on blood concentrations of biomarkers of AF-related pathways could help understand AF pathophysiology and contribute to AF prevention. : We studied 532 participants enrolled in the PREDIMED-Plus trial, a Spanish randomized trial conducted in adults (55-75 years) with metabolic syndrome and body mass index between 27-40 kg/m . Eligible participants were randomized 1:1 to an intensive lifestyle intervention, emphasizing physical activity, weight loss, and adherence to an energy-reduced Mediterranean diet or to a control group. Serum biomarkers [carboxy-terminal propeptide of procollagen type I (PICP), high-sensitivity troponin T (hsTnT), high-sensitivity C reactive protein (hsCRP), 3-nitrotyrosine (3-NT), and N-terminal propeptide of B-type natriuretic peptide (NT-proBNP)] were measured at baseline, 3 and 5 years after randomization. Mixed models were used to evaluate the effect of intervention on changes in biomarkers through year 5. Mediation analysis was performed to examine the proportion mediated by each component of the intervention. : At baseline, participants' mean age was 65, 40% were female, and 50% were assigned to the intervention. After five years, mean changes in log-transformed biomarkers were -0.01 (PICP), 0.20 (hsTnT), -0.17 (hsCRP), 0.12 (3-NT), and 0.27 (NT-proBNP). Compared to the control group, participants in the intervention group experienced greater decreases in hsCRP (-14%, 95% confidence interval (CI) -26%, 0%) or smaller increases in 3-NT (-16%, 95% CI -25%, -5%) and NT-proBNP (-12%, 95% CI -23%, 1%). The intervention had minimal impact on hsTnT (-3%, 95% CI -7%, 2%) or PICP concentrations (-2%, 95% CI -9%, 6%). The effect of the intervention on hsCRP was primarily mediated by weight loss (89% at year 5). : Over five years, a dietary and lifestyle intervention for weight-loss favorably affected concentrations of hsCRP, 3-NT, and NT-proBNP, pointing to specific mechanisms in pathways linking lifestyles and AF.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38610897</pmid><doi>10.3390/jcm13072132</doi><orcidid>https://orcid.org/0000-0002-2225-8323</orcidid><orcidid>https://orcid.org/0000-0003-2700-7459</orcidid><orcidid>https://orcid.org/0000-0002-6263-4434</orcidid><orcidid>https://orcid.org/0000-0002-5762-8558</orcidid><orcidid>https://orcid.org/0000-0003-2945-7509</orcidid><orcidid>https://orcid.org/0000-0003-3835-5598</orcidid><orcidid>https://orcid.org/0000-0003-3480-2645</orcidid><orcidid>https://orcid.org/0000-0002-3917-9808</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2024-04, Vol.13 (7), p.2132
issn 2077-0383
2077-0383
language eng
recordid cdi_proquest_miscellaneous_3038440248
source PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Analysis
Atrial fibrillation
Biological markers
Biomarkers
Blood pressure
Body mass index
Cardiac arrhythmia
Cholesterol
Complications and side effects
Creatinine
Demographic aspects
Diet
Exercise
Health aspects
Inflammation
Influence
Life style
Lifestyles
Metabolic diseases
Metabolic syndrome
Overweight
Oxidative stress
Pathophysiology
Population
Public health
Questionnaires
Risk factors
Sample size
Weight control
title Effect of an Intensive Lifestyle Intervention on Circulating Biomarkers of Atrial Fibrillation-Related Pathways among Adults with Metabolic Syndrome: Results from a Randomized Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T03%3A07%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20an%20Intensive%20Lifestyle%20Intervention%20on%20Circulating%20Biomarkers%20of%20Atrial%20Fibrillation-Related%20Pathways%20among%20Adults%20with%20Metabolic%20Syndrome:%20Results%20from%20a%20Randomized%20Trial&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Li,%20Linzi&rft.date=2024-04-07&rft.volume=13&rft.issue=7&rft.spage=2132&rft.pages=2132-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm13072132&rft_dat=%3Cgale_proqu%3EA790019561%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3037439121&rft_id=info:pmid/38610897&rft_galeid=A790019561&rfr_iscdi=true